The time from motor symptoms onset to the diagnosis of Parkinson's disease (PD) in Mexico;Tiempo desde el inicio de los síntomas motores hasta el diagnóstico de enfermedad de parkinson (Ep) en méxico

Gaceta Medica de Mexico

Volumn 150, Issue , 2014, Pages 242-247

  Arriaga, Amin Cervantes ^a   Violante, Mayela Rodríguez ^a   Ordóñez, Azyadeh Camacho ^a   Latapi, Paulina González ^a   Ruiz, Minerva López ^b   Bellmann, Ingrid Estrada ^c   Ramírez, Carlos Zúñiga ^d   Cerdeira, Elisa Otero ^e  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^d HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^e HOSPITAL ESPAÑOL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; HUMAN; MEXICO; MOTOR PERFORMANCE; PARKINSON DISEASE; PREDICTIVE VALUE; SYMPTOM ASSESSMENT;

EID: 84922295376     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Meissner WG. When does Parkinson’s disease begin? From prodromal disease to motor signs. Rev Neurol. 2012;168(11):809-14.
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-4.
3. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol. 2000;57(3):369-72.
4. Pahwa R, Lyons KE. Early diagnosis of Parkinson’s disease: recommendations from diagnositic clinical guidelines. Am J Manag Care. 2010;16 Suppl Implications:S94-9.
5. Cervantes-Arriaga A, Rodriguez-Violante M, Zuniga-Ramirez C, et al. Protocolo de estudio para una cohorte multicentrica de pacientes mexicanos con enfermedad de Parkinson para evaluar los determinantes motores, no motores y geneticos sobre la progresion. Arch Neurocien (Mex). 2012;17(3):159-64.
6. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745-52.
7. Grosset D, Taurah L, Burn DJ, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry. 2007;78(5):465-9.
8. Murphy R, Tubridy N, Kevenlighan H, O’Riordan S. Parkinson’s disease: how is employment affected? Ir J Med Sci. 2013;182(3):415-9.
9. Parkinson Study Group. DATATOP: A multicenter controlled clinical trial in early Parkinson’s disease. Arch Neurol. 1989;46(10):1052-9.
10. Martínez-Martín P, Hernández B2, Ricart J; FAST Study Group. Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson’s disease. Neurologia. 2014;29(3):153-60.
11. Femi OL, Ibrahim A, Aliyu S. Clinical profile of parkinsonian disorders in the tropics: Experience at Kano, northwestern Nigeria. J Neurosci Rural Pract. 2012;3(3):237-41.
12. Saunders-Pullman R, Wang C, Stanley K, Bressman SB. Diagnosis and referral delay in women with Parkinson’s disease. Gend Med. 2011;8(3):209-17.
13. Breen DP, Evans JR, Farrell K, Brayne C, Barker RA. Determinants of delayed diagnosis in Parkinson’s disease. J Neurol. 2013;260(8):1978-81.
14. Okubadejo UN, Ojo OO, Oshinaike OO. Clinical profile of Parkinsonism and Parkinson’s disease in Lagos, Southwestern Nigeria. BMC Neurol. 2010;10:1.
15. Rana AQ, Siddiqui I, Yousuf MS. Challenges in diagnosis of young onset Parkinson’s disease. J Neurol Sci. 2012;323(1-2):113-6.
16. Crawford P, Zimmerman EE. Differentiation and diagnosis of tremor. Am Fam Physician. 2011;83(6):697-702.
17. Thacker EL, Ascherio A. Familial aggregation of Parkinson’s disease: a meta-analysis. Mov Disord. 2008;23(8):1174-83.
18. Farnikova K, Krobot A, Kanovsky P. Musculoskeletal problems as an initial manifestation of Parkinson’s disease: a retrospective study. J Neurol Sci. 2012;319(1-2):102-4.
19. Wickremaratchi MM, Knipe MD, Sastry BS, et al. The motor phenotype of Parkinson’s disease in relation to age at onset. Mov Disord. 2011;26(3):457-63.
20. National Collaborating Centre for Chronic Conditions. Parkinson’s disease: national clinical guideline for diagnosis and management in primary and secondary care. NICE Clinical Guidelines, N.o 35. Londres: Royal College of Physicians; 2006.
21. Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and pharmacological management of Parkinson’s disease. A national clinical guideline. Edimburgo: Scottish Intercollegiate Guidelines Network (SIGN); 2010.
22. Centro Nacional de Excelencia Tecnologica en Salud (CENETEC). SSA-153-08: Diagnostico y tratamiento de la Enfermedad de Parkinson inicial en el primer nivel de atencion. Mexico: Secretaria de Salud; 2008.